Brief

"On 25/04/2025, the Korea Food and Drug Administration (KFDA) issued an update regarding Food and Drug Safety Evaluation Institute, Korea Biotechnology Research Institute signed a business agreement (MOU). The MOU aims to strengthen cooperation in research and regulation science for advanced biomedical products, including bio-drugs, pharmaceuticals, and toxicity evaluation. This collaboration is expected to lead to the development of innovative medical products and enhanced regulatory science."

This content is restricted.

Highlights content goes here...

This content is restricted.

Korea Food and Drug Administration (KFDA)

Quick Insight
RADA.AI
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Enter your registered username/email id.

Enter your Email

Enter your email id below to signup.
Individual Plan
$125 / month OR $1250 / year
Features
Best for: Researchers, Legal professionals, Academics
Enterprise Plan
Contact for Pricing
Features
Best for: Law Firms, Corporations, Government Bodies